Ravagalimab Vs Placebo in Subjects with Moderately to Severely Active Primary Sjogren's Syndrome
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled Study of Ravagalimab in Subjects with Moderately to Severely Active Primary Sjogren’s Syndrome. A Phase 2a, Double-Blind, Randomized, Placebo-Controlled Study of Ravagalimabin Subjects with Modera ...
Moderately to Severely Active Primary Sjogren's Syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrome;System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Moderately to Severely Active Primary Sjogren's Syndrome MedDRA version: 21.0;Level: PT;Classificati ...